Comparative efficacy of advanced treatments in biologic-naïve or biologic-experienced patients with ulcerative colitis: a systematic review and network meta-analysis

BACKGROUND: Only one head-to-head comparison of advanced treatments in moderately to severely active ulcerative colitis (UC) has been published; therefore, there remains a need for further comparisons. AIM: The relative treatment effects of filgotinib and adalimumab, golimumab, infliximab, tofacitin...

Descripción completa

Detalles Bibliográficos
Autores principales: Lu, Xiaoyan, Jarrett, James, Sadler, Susannah, Tan, Min, Dennis, James, Jairath, Vipul
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2022
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10147762/
https://www.ncbi.nlm.nih.gov/pubmed/36484968
http://dx.doi.org/10.1007/s11096-022-01509-1

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10147762/
https://www.ncbi.nlm.nih.gov/pubmed/36484968
http://dx.doi.org/10.1007/s11096-022-01509-1

Ejemplares similares